|
US6127356A
(en)
|
1993-10-15 |
2000-10-03 |
Duke University |
Oxidant scavengers
|
|
US20050171198A1
(en)
*
|
1997-06-20 |
2005-08-04 |
Metaphore Pharmaceuticals, Inc. |
SODm therapy for treatment, prevention, inhibition and reversal of inflammatory disease
|
|
US6214817B1
(en)
*
|
1997-06-20 |
2001-04-10 |
Monsanto Company |
Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity
|
|
US20060270639A1
(en)
*
|
1997-06-20 |
2006-11-30 |
Daniela Salvemini |
Combinations of superoxide dismutase mimetics and nonsteroidal analgesic/anti-inflammatory drugs
|
|
WO1999023097A1
(en)
|
1997-11-03 |
1999-05-14 |
Duke University |
Substituted porphyrins
|
|
ATE312103T1
(de)
|
1999-01-25 |
2005-12-15 |
Nat Jewish Med & Res Center |
Substituierte porphyrine und deren therapeutische verwendungen
|
|
AU5048400A
(en)
*
|
1999-05-27 |
2000-12-18 |
Monsanto Company |
Biomaterials modified with superoxide dismutase mimics
|
|
US20030069281A1
(en)
*
|
2000-06-14 |
2003-04-10 |
Irwin Fridovich |
Tetrapyrroles
|
|
US20020072512A1
(en)
*
|
2000-12-08 |
2002-06-13 |
Metaphore Pharmaceuticals, Inc |
Method of preventing and treating HIV-mediated central nervous system damage
|
|
JP4331939B2
(ja)
*
|
2001-01-05 |
2009-09-16 |
メタファー・ファーマシューティカルズ・インコーポレイテッド |
サイトカイン活性を増強させ、そしてサイトカインの投与に伴う低血圧を治療するための組成物および方法
|
|
DE60233317D1
(de)
|
2001-01-19 |
2009-09-24 |
Nat Jewish Med & Res Center |
Medikament zum schutz in der radiotherapie
|
|
EP1353655A2
(en)
*
|
2001-01-26 |
2003-10-22 |
Metaphore Pharmaceuticals Inc. |
Method of treatment of neurodegenerative disorders using pentaaza-macrocyclic ligand complexes
|
|
CA2439971A1
(en)
*
|
2001-03-02 |
2002-09-12 |
Metaphore Pharmaceuticals, Inc. |
Chromatography of metal complexes
|
|
US20040137638A1
(en)
|
2002-03-04 |
2004-07-15 |
Slomczynska Urszula J. |
Chromatography of metal complexes
|
|
EP1439842A4
(en)
*
|
2001-06-01 |
2009-09-02 |
Nat Jewish Med & Res Center |
OXIDANT CAPTAIN FOR THE TREATMENT OF DIABETES OR FOR THE USE IN THE TRANSPLANTATION OR INDUCTION OF IMMUNOTOLERANE
|
|
US20040236519A1
(en)
*
|
2001-06-08 |
2004-11-25 |
Marshall Garland R. |
Libraries of confomationally constrained peptides, chiral azacrowns, and peptidomimetics and methods of making the same
|
|
CA2451602A1
(en)
*
|
2001-06-26 |
2003-01-03 |
Metaphore Pharmaceuticals, Inc. |
Combination therapy of an sodm and a corticosteroid for prevention and/or treatment of inflammatory disease
|
|
EP1450824A4
(en)
*
|
2001-11-02 |
2005-09-28 |
Elan Corp Plc |
PHARMACEUTICAL COMPOSITION
|
|
WO2003051458A1
(en)
*
|
2001-12-14 |
2003-06-26 |
Alcon, Inc. |
Superoxide dismutase mimics for the treatment of ocular disorders and diseases
|
|
US6933275B2
(en)
*
|
2002-05-01 |
2005-08-23 |
The Board Of Trustees Of The Leland Stanford Junior University |
Protein kinase C peptides for use in withdrawal
|
|
US7485721B2
(en)
*
|
2002-06-07 |
2009-02-03 |
Duke University |
Substituted porphyrins
|
|
US20030232784A1
(en)
*
|
2002-06-14 |
2003-12-18 |
Benedict James J. |
Hyaluronic acid-associated superoxide dismutase mimics and their use in the treatment of joint pain
|
|
CA2397684A1
(en)
*
|
2002-08-12 |
2004-02-12 |
Michael P. Murphy |
Mitochondrially targeted antioxidants
|
|
EP1551402A4
(en)
*
|
2002-09-23 |
2009-05-27 |
Verion Inc |
PHARMACEUTICAL COMPOSITIONS NOT INDUCING ABUSE
|
|
MXPA05005937A
(es)
*
|
2002-12-06 |
2005-08-18 |
Alcon Inc |
Imitaciones de superoxido de dismutasa para el tratamiento de trastornos y enfermedades oculares.
|
|
CN1717234A
(zh)
*
|
2002-12-06 |
2006-01-04 |
爱尔康公司 |
用于治疗眼紊乱和疾病的超氧化物岐化酶模拟物
|
|
KR100648618B1
(ko)
*
|
2003-11-19 |
2006-11-23 |
주식회사 웰스킨 |
활성 산소 억제제
|
|
MXPA06006187A
(es)
*
|
2003-12-11 |
2006-08-25 |
Alcon Inc |
Imitadores de super oxido dismutasa para el tratamiento de dano retinal y de nervio optico.
|
|
US8217166B2
(en)
*
|
2005-05-05 |
2012-07-10 |
Galera Therapeutics, Llc |
Polyethylene glycolated superoxide dismutase mimetics
|
|
US20120301403A1
(en)
|
2007-06-21 |
2012-11-29 |
Galera Therapeutics, Llc |
Polyethylene glycolated superoxide dismutase mimetics
|
|
WO2006069326A2
(en)
*
|
2004-12-21 |
2006-06-29 |
Metaphore Pharmaceuticals, Inc. |
Polyethylene glycolated superoxide dismutase mimetics
|
|
KR100724586B1
(ko)
|
2005-12-09 |
2007-06-04 |
세종대학교산학협력단 |
수퍼옥사이드 디스뮤타아제 활성을 갖는 고리화합물
|
|
ES2725023T3
(es)
|
2006-10-12 |
2019-09-18 |
Galera Labs Llc |
Métodos para el tratamiento de la mucositis oral
|
|
US8486928B2
(en)
|
2007-11-14 |
2013-07-16 |
Galera Therapeutics |
Super-oxide dismutase mimetics
|
|
EP2296645B1
(en)
|
2008-05-22 |
2014-11-19 |
Galera Therapeutics, LLC |
Combination antitumor therapy
|
|
CN102105146A
(zh)
|
2008-05-23 |
2011-06-22 |
国立犹太保健医院 |
用于治疗与暴露于烷化物质有关的损伤的方法
|
|
EP2760874A4
(en)
*
|
2011-09-26 |
2015-04-08 |
Galera Therapeutics Llc |
METHOD FOR THE TREATMENT OF ILLNESSES
|
|
RS60558B1
(sr)
|
2015-08-11 |
2020-08-31 |
Galera Labs Llc |
Pentaaza makrociklični prstenasti kompleksi koji poseduju oralnu bioraspoloživost
|
|
KR20180132939A
(ko)
|
2016-05-03 |
2018-12-12 |
갈레라 랩스, 엘엘씨 |
암 치료를 위한 조합 요법
|
|
JP7166634B2
(ja)
|
2016-09-01 |
2022-11-08 |
ガレラ・ラブス・リミテッド・ライアビリティ・カンパニー |
ペンタアザ大環状環複合体およびアスコルビン酸化合物による組み合わせ癌療法
|
|
CA3053779A1
(en)
*
|
2017-02-15 |
2018-08-23 |
Galera Labs, Llc |
Pentaaza macrocyclic ring complexes for local intestinal delivery
|
|
EP3388082A1
(en)
|
2017-04-13 |
2018-10-17 |
Galera Labs, LLC |
Combination cancer immunotherapy with pentaaza macrocyclic ring complex
|
|
IL295620B2
(en)
|
2017-04-13 |
2024-01-01 |
Galera Labs Llc |
Combination cancer immunotherapy with pentaaza macrocyclic ring complex
|
|
CA3090129A1
(en)
|
2018-01-31 |
2019-08-08 |
Galera Labs, Llc |
Combination cancer therapy with pentaaza macrocyclic ring complex and platinum-based anticancer agent
|
|
US20230071463A1
(en)
*
|
2020-02-13 |
2023-03-09 |
Teva Pharmaceuticals International Gmbh |
Solid state forms of avasopasem manganese and process for preparation thereof
|
|
AU2024300676A1
(en)
*
|
2023-07-21 |
2026-01-29 |
Board Of Regents Of The University Of Texas System |
Carcinogenesis reduction with pentaaza macrocyclic ring complex
|